ANKRD11 Antikörper (N-Term)
Kurzübersicht für ANKRD11 Antikörper (N-Term) (ABIN629618)
Target
Alle ANKRD11 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- ANKRD11 antibody was raised against the N terminal of ANKRD11
-
Aufreinigung
- Purified
-
Immunogen
- ANKRD11 antibody was raised using the N terminal of ANKRD11 corresponding to a region with amino acids KRKLPFTAGANGEQKDSDTEKQGPERKRIKKEPVTRKAGLLFGMGLSGIR
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
ANKRD11 Blocking Peptide, (ABIN940013), is also available for use as a blocking control in assays to test for specificity of this ANKRD11 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ANKRD11 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ANKRD11 (Ankyrin Repeat Domain 11 (ANKRD11))
-
Andere Bezeichnung
- ANKRD11
-
Hintergrund
- ANKRD11 is a member of a novel family of ankyrin repeats containing cofactors (ANCOs) that interact with p160 coactivators to inhibit ligand-dependent transactivation. ANKRD11 encodes a large nuclear protein with five ankyrin repeats, and parts of its sequences have been reported as nasopharyngeal carcinoma susceptibility protein and medulloblastoma antigen. This gene also colocalizes and interacts with histone deacetylases.
-
Molekulargewicht
- 298 kDa (MW of target protein)
Target
-